Get to Know Dr. David Johnstone
Dr. David Johnstone believes strongly in the multidisciplinary approach to thoracic malignancies such as mesothelioma, and the personalization of treatment that each patient receives at Froedtert Hospital.
Johnstone joined Froedtert and the Medical College of Wisconsin in 2011 after a distinguished career at Dartmouth-Hitchcock Medical Center in New Hampshire, where he served as the director of the thoracic oncology program.
He specializes in cardiothoracic and thoracic surgeries, mesothelioma treatments, lung cancer and other malignancies. Johnstone also supervises the weekly thoracic tumor board meetings at Froedtert Hospital, where surgeons, medical oncologists, mesothelioma doctors, radiologists, pathologists and nurses discuss each case and its treatment direction.
“My philosophy is to provide patients with a full evaluation, as complete a range of options for management, as we can devise,” Johnstone said. “It is the patient’s job to decide which options they would be comfortable with. Our job is to provide them with the knowledge.”
Specialties of Dr. David Johnstone
- Lung cancer
- Pleural mesothelioma
- Esophageal cancer
- Chest wall tumors
- Mediastinal tumors
- Hiatal hernia
- Tracheal surgery
- Lung volume reduction surgery
Dr. David Johnstone’s Experience and Medical Education
- Froedtert Hospital and Medical College of Wisconsin
- Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center
- Memorial Sloan Kettering Cancer Center (Residency)
- Columbia Presbyterian Medical Center (Fellowship)
- Northwestern University Medical School (M.D.)
Awards and Other Recognitions
- America’s Top Doctors Award
- America’s Top Doctors for Cancer Award
- Castle Connolly’s America’s Top Doctors
- ACS fellow
- American Board of Thoracic Surgery certification
Publications of Dr. David Johnstone
- Johnstone, D. (2015, December 15). CT Screening for Lung Cancer: How to Fulfill the Promise. Oncology.
- Wyler von Ballmoos, M., Johnstone, D. (2014, August 29). Outcomes in thoracic surgical management of non-small cell lung cancer. Journal of Surgical Oncology.
- Timmerman, R. et al. (2010, March 17). Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer. JAMA.